JUN and meningioma: Considering inconsistent expression of SOS2/KRAS and JUN/FOS in fibroblastic meningioma, we speculated that activated Ras promoted tumor growth through the PI3K/Akt pathway, but not via ERK-c-Jun/c-Fos pathway.